ACLX20250516P90
ACLX May 16 2025 90.00 Put (ACLX250516P00090000)
option OPRA

Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.